1.Karayiorgou, M, Gogos, JA.A turning point in schizophrenia genetics. Neuron 1997;19:967–979.
2.Hanson, DR, Gottesman, II.Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 2005;6:7.
3.Gogos, JA, Gerber, DJ.Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 2006;27:226–233.
4.Iizuka, Y, Sei, Y, Weinberger, DR, Straub, RE.Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 2007;27:12390–12395.
5.Li, D, He, L.Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res 2007;96:112–118.
6.Owen, MJ, Craddock, N, Jablensky, A.The genetic deconstruction of psychosis. Schizophr Bull 2007;33:905–911.
7.Harrison, PJ, Owen, MJ.Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003;361:417–419.
8.Veroni, C, Grasso, M, Macchia, G, Ramoni, C, Ceccarini, M, Petrucci, TC, Macioce, P.Beta-dystrobrevin, a kinesin-binding receptor, interacts with the extracellular matrix components pancortins. J Neurosci Res 2007;85:2631–2639.
9.Benson, MA, Newey, SE, Martin-Rendon, E, Hawkes, R, Blake, DJ.Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001;276:24232–24241.
10.Pimm, J, McQuillin, A, Thirumalai, S, et al. The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am J Hum Genet 2005;76: 902–907.
11.Nazarian, R, Starcevic, M, Spencer, MJ, Dell'Angelica, EC.Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein. Biochem J 2006;395: 587–598.
12.Knuesel, I, Mastrocola, M, Zuellig, RA, Bornhauser, B, Schaub, MC, Fritschy, JM.Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 1999;11:4457–4462.
13.Krystal, JH, Sanacora, G, Blumberg, H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002;7(Suppl. 1):S71–S80.
14.D'Sa, C, Duman, RS.Antidepressants and neuroplasticity. Bipolar Disord 2002;4:183–194.
15.McLeod, TM, Lopez-Figueroa, AL, Lopez-Figueroa, MO.Nitric oxide, stress, and depression. Psychopharmacol Bull 2001;35:24–41.
16.Brambilla, P, Perez, J, Barale, F, Schettini, G, Soares, JC.GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:721–737.
17.Duman, RS, Malberg, J, Nakagawa, S, D'Sa, C.Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000;48:732–739.
18.Straub, RE, Jiang, Y, MacLean, CJ, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002;71:337–348.
19.Schwab, SG, Knapp, M, Mondabon, S, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003;72:185–190.
20.Tang, JX, Zhou, J, Fan, JB, et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 2003;8:717–718.
21.Kirov, G, Ivanov, D, Williams, NM, et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004;55:971–975.
22.De Luca, V, Voineskos, D, Shinkai, T, Wong, G, Kennedy, JL.Untranslated region haplotype in dysbindin gene: analysis in schizophrenia. J Neural Transm 2005;112: 1263–1267.
23.Van Den Bogaert, A, Schumacher, J, Schulze, TG, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003;73:1438–1443.
24.Kishimoto, M, Ujike, H, Motohashi, Y, et al. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 2008;63:191–196.
25.Benjamini, Y, Hochberg, Y.Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological) 1995;57:289–300.
26.Benjamini, Y, Krieger, AM, Yekutieli, D.Adaptive linear step-up procedures that control the false discovery rate. Biometrika 2006;93:491–507.
27.Stephens, M, Smith, NJ, Donnelly, P.A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978–989.
28.Tochigi, M, Zhang, X, Ohashi, J, et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 2006;56: 154–158.
29.Joo, EJ, Lee, KY, Jeong, SH, Ahn, YM, Koo, YJ, Kim, YS.The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neurosci Lett 2006;407:101–106.
30.Galehdari, H, Ajam, T, Pooryasin, A, Foroughmand, AM, Kazeminejad, SR.Combined effect of polymorphic sites in the DTNBP1 and GRIN1 genes on schizophrenia. MJIRI 2010;24:5–10.
31.Tosato, S, Ruggeri, M, Bonetto, C, et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2007;144B:647–659.
32.Williams, NM, Preece, A, Morris, DW, et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004;61:336–344.
33.Bray, NJ, Preece, A, Williams, NM, Moskvina, V, Buckland, PR, Owen, MJ, O'Donovan, MC.Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005;14:1947–1954.
34.Numakawa, T, Yagasaki, Y, Ishimoto, T, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004;13: 2699–2708.
35.Talbot, K, Eidem, WL, Tinsley, CL, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004;113:1353–1363.
36.Weickert, CS, Straub, RE, McClintock, BW, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004;61:544–555.